Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory

Clinical Microbiology and Infection

Volumn 16, Issue 8, 2010, Pages 1084-1089

  Eveillard, M ^a   Lemarie C ^a   Cottin, J ^a   Hitoto, H ^a   Mahaza, C ^a   Kempf, M ^a   Joly Guillou, M L ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Antimicrobial resistance; Antimicrobial therapy; Clinical microbiology laboratory; Night service; Patient management

Indexed keywords

BETA LACTAM ANTIBIOTIC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL LABORATORY; CONTROLLED STUDY; EARLY DIAGNOSIS; EARLY INTERVENTION; ECONOMIC ASPECT; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; LABORATORY TEST; MEDICAL STAFF; MICROBIOLOGICAL PARAMETERS; MICROBIOLOGY; NIGHT WORK; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TREATMENT PLANNING; URINE CULTURE; BACTERIA; BACTERIAL INFECTIONS; BODY FLUID; CLASSIFICATION; DRUG EFFECTS; HEALTH SERVICES RESEARCH; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; TIME; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BODY FLUIDS; DIAGNOSTIC SERVICES; HEALTH SERVICES RESEARCH; HUMANS; MICROBIAL SENSITIVITY TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954630832     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03044.x     Document Type: Article

References (27)

1. Kang CI, Kim SH, Park WB. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy and outcome. Antimicrob Agents Chemother 2005, 49:760-766.
2. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
3. Luna CM, Aruj P, Niederman MS. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006, 27:158-164.
4. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia. Link between quality of care and resource utilization. Arch Intern Med 2002, 162:682-688.
5. Albrecht SJ, Fishman NO, Kitchen J. Reemergence of Gram-negative health care-associated bloodstream infections. Arch Intern Med 2006, 166:1289-1294.
6. D'Agata EMC. Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study. Infect Control Hosp Epidemiol 2004, 25:842-846.
7. Pop-Vicas A, Taconelli E, Gravenstein S, Lu B, D'Agata EMC. Influx of multidrug-resistant, Gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection. Infect Control Hosp Epidemiol 2009, 30:325-331.
8. Hirschman SZ, Meyers BR, Bradnury K, Mehl B, Gendelman S, Kimelblatt B. Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive control programme. Ann Intern Med 1988, 148:2001-2007.
9. Berild D, Mohseni A, Diep LM, Jensenius M, Ringertz SH. Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs. J Antimicrob Chemother 2006, 57:326-330.
10. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31(suppl 4):S131-S138.
11. Kollef MH, Sherman G, Ward S. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474.
12. Cunney RJ, McNamara EB, Alansari N, Smyth EG. The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia. J Clin Pathol 1997, 50:1010-1012.
13. Fitzpatrick F, Turley M, Humphreys H, Smyth E. An after-hours clinical liaison blood culture service-is it worth it? Clin Microbiol Infect 2004, 10:917-921.
14. Beekmann SE, Diekema DJ, Chapin KC, Doern GV. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol 2003, 41:3119-3125.
15. Rand KH, Tillan M. Errors in interpretation of Gram stains from positive blood cultures. Am J Clin Pathol 2006, 126:671-672.
16. Barenfanger J, Graham DR, Kolluri L. Decreased mortality associated with prompt Gram staining of blood cultures. Am J Clin Pathol 2008, 130:870-876.
17. Fraser A, Paul M, Almanasreh N. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med 2006, 119:970-976.
18. Marcus N, Ashkenazi S, Samra Z, Cohen A, Livni G. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment. Infection 2008, 36:421-426.
19. Marcus N, Ashkenazi S, Yaari A, Samra Z, Livni G. Non-Escherichia coli versus Escherichia coli community-acquired urinary-tract infections in patients hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and outcome. Pediatr Infect Dis J 2005, 24:581-585.
20. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing enterobacteriaceae. Arch Intern Med 2005, 165:1375-1380.
21. Rodriguez-Bano J, Millan AB, Angeles Dominguez M. Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus. J Infect 2009, 58:131-137.
22. Kim SH, Park WB, Lee KD. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2004, 54:489-497.
23. Zaragoza R, Artero A, Camarena JJ, Sancho S, Gonzalez R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003, 9:412-418.
24. Marschall J, Agniel D, Fraser VJ, Doherty J, Warren DK. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate therapy and impact on outcomes. J Antimicrob Chemother 2008, 61:1376-1383.
25. Lin MY, Weinstein RA, Hota B. Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob Agents Chemother 2008, 52:3188-3194.
26. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003, 115:529-535.
27. Bouza E, Torres MV, Radice C. Direct E-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia. Clin Infect Dis 2007, 44:382-387.